4 January 2022
Events
5 – 7 Jan 2022 – 11th Annual LifeSci Partners Corporate Access Event
Small Pharma is pleased to announce its attendance at the 11th Annual LifeS
Resources
4 January 2022
Events
10-13 Jan 2022 – H.C. Wainwright Bioconnect Conference
Small Pharma is participating in the H.C. Wainwright Bioconnect Conference
1 December 2021
Events
6 Dec 2021 – H.C. Wainwright Psychedelics Virtual Conference
Small Pharma is participating in the H.C. Wainwright 2nd Annual Psychedelic
18 November 2021
Press Releases
Small Pharma Strengthens Board With Appointment Of Paul Maier As Independent Director
LONDON, Nov. 15, 2021 -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (th
15 November 2021
Press Releases
Discussions With FDA Provide Guidance For Phase IIb Clinical Trial Design For DMT-assisted Therapy For Major Depressive Disorder
LONDON, Nov. 15, 2021 -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (th
15 November 2021
Events
16-19 Nov 21 – The Jefferies Healthcare Conference
The Jefferies London Healthcare Conference will consist of both in-person o
12 November 2021
Press Releases
Small Pharma to Attend Upcoming Healthcare Conferences in November 2021
LONDON, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OT
10 November 2021
Events
10-15 Nov 21 – LSX Inv€$tival Showcase conference.
Small Pharma is participating in the LSX Inv€$tival ShowcaseTM conference
1 November 2021
Press Releases
Small Pharma reports second quarter highlights
LONDON, Sept. 21, 2021 /PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "
25 October 2021
Press Releases
European Patent Grant Strengthens Small Pharma’s Ketamine-based Patent Portfolio For The Treatment Of Depressive Disorders
LONDON, Sept. 21, 2021 /PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "
TSXV:DMT
OTCQB:DMTTF
About Small Pharma
We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.
With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.